Mercator Medical S.A. (MRC) — Working Capital to Net Assets Ratio
Mercator Medical S.A. (MRC) has a Working Capital to Net Assets ratio of 53.4% as of September 2025. Working capital of zł474.87 Million (current assets of zł554.63 Million minus current liabilities of zł79.76 Million) is measured against net assets of zł890.05 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Mercator Medical S.A.'s balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Mercator Medical S.A. Working Capital to Net Assets (2012–2024)
This chart shows how Mercator Medical S.A.'s Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 53.4%, reflecting working capital of zł474.87 Million against net assets of zł890.05 Million PLN. Check Mercator Medical S.A. (MRC) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Mercator Medical S.A. (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Mercator Medical S.A. from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Mercator Medical S.A. market capitalisation.
| Year | WC/NA Ratio | Working Capital (PLN) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 58.1% | zł537.80 Million | zł925.16 Million | zł634.67 Million | zł96.87 Million | ▼ -0.8 pp |
| 2023 | 58.9% | zł506.76 Million | zł859.71 Million | zł585.24 Million | zł78.47 Million | ▼ -4.2 pp |
| 2022 | 63.2% | zł637.60 Million | zł1.01 Billion | zł697.56 Million | zł59.96 Million | ▼ -5.0 pp |
| 2021 | 68.2% | zł781.12 Million | zł1.15 Billion | zł914.17 Million | zł133.05 Million | ▼ -13.8 pp |
| 2020 | 82.0% | zł855.63 Million | zł1.04 Billion | zł1.10 Billion | zł239.89 Million | ▲ +53.5 pp |
| 2019 | 28.6% | zł38.41 Million | zł134.46 Million | zł191.06 Million | zł152.65 Million | ▲ +5.2 pp |
| 2018 | 23.3% | zł31.12 Million | zł133.29 Million | zł192.91 Million | zł161.79 Million | ▼ -8.6 pp |
| 2017 | 32.0% | zł38.30 Million | zł119.74 Million | zł143.30 Million | zł105.01 Million | ▼ -11.9 pp |
| 2016 | 43.8% | zł54.12 Million | zł123.46 Million | zł123.67 Million | zł69.55 Million | ▼ -5.6 pp |
| 2015 | 49.4% | zł35.92 Million | zł72.70 Million | zł89.13 Million | zł53.21 Million | ▲ +10.1 pp |
| 2014 | 39.3% | zł26.39 Million | zł67.21 Million | zł74.39 Million | zł48.00 Million | ▼ -8.1 pp |
| 2013 | 47.4% | zł27.07 Million | zł57.13 Million | zł64.44 Million | zł37.36 Million | ▲ +24.6 pp |
| 2012 | 22.8% | zł5.62 Million | zł24.69 Million | zł42.75 Million | zł37.13 Million | — |